Company profile: Rhenovia
1.1 - Company Overview
Company description
- Provider of applications of biosimulation rooted in neuroscience and nervous system modeling, from a French biotechnology company founded in 2007 by managers from large pharmaceutical companies and world experts.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Rhenovia
DFE Pharma
HQ: Germany
Website
- Description: Provider of excipient solutions for pharmaceutical, biopharmaceutical, and nutraceutical industries, developing, producing, and supplying functional excipients used as fillers, binders, disintegrants, and stabilizers. Offers BioHale excipients to stabilize biologics across parenteral, inhalation, oral, and ophthalmic routes, an online formulation tool, and technical, regulatory, quality, and formulation support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DFE Pharma company profile →
Facility Logix
HQ: United States
Website
- Description: Provider of biotech, pharma, and life sciences facility solutions, offering GxP compliance services (consulting, software, lab support, certification), advisory services (cost advisory, owner's representation, facility startup), GxP consulting (operations strategy, facility design, risk management, best practices), CQV services, GMP environmental monitoring, and temporary on‑premise cleanrooms for short- or long-term rentals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Facility Logix company profile →
Topo Therapeutics
HQ: United States
Website
- Description: Provider of structural biology expertise to accelerate transmembrane protein drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Topo Therapeutics company profile →
Careform
HQ: United States
Website
- Description: Provider of technology-enabled hub services that drive patient and provider engagement and support, simplifying access to specialty pharmaceuticals through patient support services. BrandHub delivers inventory management, EHR integration, and therapy cycle management to identify and remove barriers to patient access, supported by logistics experts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Careform company profile →
Surface Ophthalmics
HQ: United States
Website
- Description: Provider of ophthalmic therapeutics leveraging the Klarity delivery vehicle, including SURF-100 topical eyedrops for chronic dry eye (Phase II), SURF-200 for acute dry eye (Phase II), SURF-201 Betamethasone 0.2% solution for post-cataract pain and inflammation (positive Phase II), and an MPA 0.1% chronic dry eye therapy ready for Phase III.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surface Ophthalmics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Rhenovia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Rhenovia
2.2 - Growth funds investing in similar companies to Rhenovia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Rhenovia
4.2 - Public trading comparable groups for Rhenovia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →